insights_auto
Zašto je EVGN pao 4,09%?
Istražite detaljnijechevron_right
EVGN:NASDAQ
Evogene Ltd
0,38 USD
arrow_downward
−4,09%(−0,016) 1D
9. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EVGN...
Otvori
0,39 USD
Najviša
0,39 USD
Najniža
0,37 USD
Trž. kap.
6,90 mil.
Prosj. kol.
2,57 mil.
Količina
106,04 tis.
52-tjed. najviša
1,49 USD
52-tjed. najniža
0,35 USD
EPS
−0,90 USD
Beta
1,44
Dionice u optjecaju
18,05 mil.
Broj djelatnika
52
Otvori
0,39 USD
Najviša
0,39 USD
Najniža
0,37 USD
Trž. kap.
6,90 mil.
Prosj. kol.
2,57 mil.
Količina
106,04 tis.
52-tjed. najviša
1,49 USD
52-tjed. najniža
0,35 USD
EPS
−0,90 USD
Beta
1,44
Dionice u optjecaju
18,05 mil.
Broj djelatnika
52
Vijesti
Iz web-izvora i od partnera za vijesti
Investing.com South Africa
·
prije 4 dana
Evogene reaches agreement with Pure Capital Group on board changes By Investing.com
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Evogene Ltd – informacije